M&T Bank’s AtriCure ATRC Stock Holding History

M&T Bank’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,060	Closed	-$279K	–	1729
2025 Q4	$279K	Buy	7,060 +904	+15%	+$33.1K	﹤0.01%	1432
2025 Q3	$217K	Buy	+6,156	New	+$212K	﹤0.01%	1353
2025 Q1	–	Sell	-6,799	Closed	-$208K	–	1564
2024 Q4	$208K	Buy	+6,799	New	+$219K	﹤0.01%	1521

Other funds holding ATRC

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

M&T Bank's ATRC Position: Q1 2026 in Review

M&T Bank sold out of AtriCure (ATRC) in Q1 2026, closing a stake of 7,060 shares — an estimated $279K sold.

M&T Bank first reported a position in ATRC in Q4 2024 and held it in 3 quarters. The position peaked at $279K in Q4 2025. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.

M&T Bank reported no remaining AtriCure position as of Q1 2026 after selling out during the quarter.
M&T Bank sold 7,060 AtriCure shares in Q1 2026, an estimated $279K.
M&T Bank first reported a position in AtriCure in Q4 2024 and held it in 3 quarters.
M&T Bank's AtriCure position peaked at $279K in Q4 2025.
224 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.

Based on M&T Bank's 13F filing for Q1 2026, filed 12 May 2026.